Scythian Biosciences Corp (SCYB.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 110 | 453 | 63 | 22 | 65 |
| Operating Expenses | 8,751 | 2,984 | 3,596 | 2,192 | 2,113 |
| Operating Income | -8,642 | -2,531 | -3,533 | -2,170 | -2,049 |
| Interest Expense | 11 | 39 | 8 | 15 | 20 |
| Other Income | 29 | -423 | -705 | -1,238 | 743 |
| Pre-tax Income | -8,624 | -2,994 | -4,246 | -3,423 | -1,326 |
| Net Income Continuous | -8,624 | -2,994 | -4,246 | -3,423 | -1,326 |
| Net Income | $-8,624 | $-2,994 | $-4,246 | $-3,423 | $-1,326 |
| EPS Basic Total Ops | -0.40 | -0.20 | -0.20 | -0.10 | -0.05 |
| EPS Basic Continuous Ops | -0.40 | -0.20 | -0.20 | -0.10 | -0.05 |
| EPS Diluted Total Ops | -0.40 | -0.20 | -0.20 | -0.10 | -0.05 |
| EPS Diluted Continuous Ops | -0.40 | -0.20 | -0.20 | -0.10 | -0.05 |
| EBITDA(a) | $-8,171 | $-3,068 | $-3,703 | $-2,505 | $-1,067 |